References

Hypertension Exercise Program

High Blood Pressure Holistic Treatments Ebook

Get Instant Access

1. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol 1981; 107(1):1-11.

2. Cook SP, Macartney KK, Rose CD, et al. Lyme disease and seventh nerve paralysis in children. Am J Otolaryngol 1997; 18(5):320-323.

3. Peltomaa M, Pyykko I, Seppala I, et al. Lyme borreliosis and facial paralysis—a prospective analysis of risk factors and outcome. Am J Otolaryngol 2002; 23(3):125-132.

4. Bingham PM, Galetta SL, Athreya B, et al. Neurologic manifestations in children with Lyme disease. Pediatrics 1995; 96(6):1053-1056.

5. Angerer M, Pfadenhauer K, Stohr M. Prognosis of facial palsy in Borrelia burgdorferi meningopolyradiculoneuritis. J Neurol 1993; 240(5):319-321.

6. http://www.cdc.gov/epo/dphsi/casedef/syphiliscurrent.htm (accessed October 2005).

7. Johnson RA, White M. Syphilis in the 1990s: cutaneous and neurologic manifestations. Semin Neurol 1992; 12(4):287-298.

8. Cintron R, Pachner AR. Spirochetal diseases of the nervous system. Curr Opin Neurol 1994; 7(3):217-222.

9. Verduijn PG, Bleeker JD. Secondary syphilis of the facial nerve. Arch Otolaryngol 1982; 108(6):382-384.

10. http://www.cdc.gov/ncidod/dbmd/diseaseinfo/hansens_t.htm (accessed October 2005).

11. Selby RC. Neurosurgical aspects of leprosy. Surg Neurol 1974; 2(3):165-177.

12. Antia NH, Divekar SC, Dastur DK. The facial nerve in leprosy. I. Clinical and operative aspects. Int J Lepr Other Mycobact Dis 1966; 34(2):103-117.

13. Reichart PA, Srisuwan S, Metah D. Lesions of the facial and trigeminal nerve in leprosy. An evaluation of 43 cases. Int J Oral Surg 1982; 11(1):14-20.

14. Beardwell A. Facial palsy due to the mumps virus. Br J Clin Pract 1969; 23(1):37-38.

15. Manning JJ, Adour KK. Facial paralysis in children. Pediatrics 1972; 49(1):102-109.

16. Endo A, Izumi H, Miyashita M, et al. Facial palsy associated with mumps parotitis. Pediatr Infect Dis J 2001; 20(8):815-816.

17. http://www.mass.gov/dph/cdc/tb/ (accessed October 2005).

18. Stone JW. Tuberculosis of the middle ear. Arch Otolaryngol 1967; 86(4):407-411.

19. Skolnik PR, Nadol JB Jr, Bake AS. Tuberculosis of the middle ear: review of the literature with an instructive case report. Rev Infect Dis 1986; 8(3):403-410.

20. Lucente FE, Tobias GW, Parisier SC, et al. Tuberculosis otitis media. Laryngoscope 1978; 88(7 pt 1):1107—1116.

21. Samuel J, Fernandes CM. Tuberculous mastoiditis. Ann Otol Rhinol Laryngol 1986; 95(3 pt 1):264—266.

22. Singh B. Role of surgery in tuberculous mastoiditis. J Laryngol Otol 1991; 105(11):907-915.

23. Harbert F, Riordan D. Tuberculosis of the middle ear. Laryngoscope 1964; 74:198-204.

24. Windle-Taylor PC, Bailey CM. Tuberculosis otitis media: a series of 22 patients. Laryngoscope 1980; 90(6 pt 1):1039-1044.

25. Plester D, Pusalkar A, Steinbach E. Middle ear tuberculosis. J Laryngol Otol 1980;94(12): 1415-1421.

26. Legent F, Baron F. Facial paralysis and tuberculosis otitis. Significance of early neural decompression. Ann Otolaryngol Chir Cervicofac 1975; 92(4-5):235-240.

27. van der Flier M, van Koppenhagen C, Disch FJ, et al. Bilateral sequential facial palsy during chickenpox. Eur J Pediatr 1999; 158(10):807-808.

28. Guldberg-Moller J, Olsen S, Kettel K. Histopathology of the facial nerve in herpes zoster oticus. AMA Arch Otolaryngol 1959; 69(3):266-275.

29. Muecke M, Amedee RG. Herpes zoster oticus: diagnosis and management. J La State Med Soc 1993; 145(8):333-335.

30. Dickins JR, Smith JT, Graham SS. Herpes zoster oticus: treatment with intravenous acyclovir. Laryngoscope 1988; 98(7):776-779.

31. Uri N, Greenberg E, Meyer W, et al. Herpes zoster oticus: treatment with acyclovir. Ann Otol Rhinol Laryngol 1992; 101(2 pt 1):161-162.

32. May M, Blumenthal F. Herpes zoster oticus: surgery based upon prognostic indicators and results. Laryngoscope 1982; 92(1):65-67.

33. Murakami S, Mizobuchi M, Nakashiro Y, et al. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996; 124(1 pt 1):27-30.

34. Friedman RA. The surgical management of Bell's palsy: a review. Am J Otol 2000; 21(1):139-144.

35. May M, Hughes GB. Facial nerve disorders: update 1987. Am J Otol 1987; 8(2):167-180.

36. Adour KK, Ruboyianes JM, Von Doersten PG, et al. Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone: a double-blind, randomized, controlled trial. Ann Otol Rhinol Laryngol 1996; 105(5):371-378.

37. Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell's palsy. Laryngoscope 1999; 109(8):1177-1188.

38. Foy HM, Kenny GE, McMahan R, et al. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA 1970; 214(9):1666-1672.

39. Levine DP, Lerner AM. The clinical spectrum of Mycoplasma pneumoniae infections. Med Clin North Am 1978; 62(5):961-978.

40. Murray HW, Masur H, Senterfit LB, et al. The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med 1975; 58(2):229-242.

41. Yesnick L. Central nervous system complications of primary atypical pneumonia. AMA Arch Intern Med 1956; 97(1):93-98.

42. Endtz LJ, Hers JF. Mycoplasma pneumoniae polyradiculitis. Lancet 1970; 1(7642):358.

43. Ernster JA. Bilateral facial nerve paralysis associated with Mycoplasma pneumonia infection. Ear Nose Throat J 1984; 63(12):585-590.

44. Klar A, Gross-Kieselstein E, Hurvitz H, et al. Bilateral Bell's palsy due to Mycoplasma pneumoniae infection. Isr J Med Sci 1985; 21(8):692-694.

45. Falk W. The 1950 Poliomyelitis Epidemic. Acta Med Orient 1951; 10:105.

46. Marberg K. Observations on poliomyelitis during the 1950 epidemic in Israel. Acta Med Orient 1952; 11(4):61-77.

47. Agius T, Bartolo AE, Coleiro C, et al. Clinical Features of Poliomyelitis Epidemic in Malta, 19421943. Br Med J 1945; 1:759.

48. Winter ST. Facial paralysis in poliomyelitis; a follow-up of 58 patients. Pediatrics 1957;

49. Moore EW. The fate of the face in poliomyelitis. Lancet 1952; 1(22):1092-1093.

50. Carpenter CCJ. Fever and febrile syndromes. In: Andreoli TE, Bennett JC, Carpenter CCJ, Plum F, eds. Cecil Essentials of Medicine. 4th ed. Philadelphia, Pennsylvania: W. B. Saunders Company, 1997:671-672.

51. Silverstein A, Steinberg G, Nathanson M. Nervous system involvement as the heralding and-or major manifestation of infectious mononucleosis. Trans Am Neurol Assoc 1971; 96:16-20.

52. Gsell O. Meningitis serosa bei pfeiffer—schem drusenfieber (mononucleosis infectiosa). Dtsch Med Wochenschr 1937; 63:1759-1762.

53. Grose C, Feorino PM, Dye LA, et al. Bell's palsy and infectious mononucleosis. Lancet 1973; 2(7823):231-232.

54. Michel RG, Pope TH Jr, Patterson CN. Infectious mononucleosis, mastoiditis, and facial paralysis. Arch Otolaryngol 1975; 101(8):486-489.

55. Snyderman NL. Otorhinolaryngologic presentations of infectious mononucleosis. Pediatr Clin North Am 1981; 28(4):1011-1016.

56. Weintraub MI. Bilateral facial palsy. A rare presentation of infectious mononucleosis. Clin Pediatr (Phila) 1977; 16(12):1158-1159.

57. Johnson PA, Avery C. Infectious mononucleosis presenting as a parotid mass with associated facial nerve palsy. Int J Oral Maxillofac Surg 1991; 20(4):193-195.

58. Strauss M. Cytomegalovirus and the otolaryngologist. Laryngoscope 1981; 91(12):1995-2006.

59. Leonard J, Tobin J. Polyneuritis associated with CMV infections. Q J Med 1971; 40:435-442.

60. Mair IW, Traavik T. Peripheral facial palsy and viral replication. Acta Otolaryngol 1983; 95(5-6):528-531.

61. Sene-Diouf F, Ndiaye M, Diop AG, et al. Epidemiological, clinical and progressive aspects of neurological manifestations associated with retroviral infections: eleven year retrospective study. Dakar Med 2000; 45(2):162-166.

62. Schielke E, Pfister HW, Einhaupl KM. Peripheral facial nerve palsy associated with HIV infection. Lancet 1989; 1(8637):553-554.

63. Belec L, Georges AJ, Vuillecard E, et al. Peripheral facial paralysis indicating HIV infection. Lancet 1988; 2(8625):1421-1422.

64. Murr AH, Benecke JE Jr. Association of facial paralysis with HIV positivity. Am J Otol 1991; 12 (6):450-451.

65. Walter RS, Eppes SC. Cat scratch disease presenting with peripheral facial nerve paralysis. Pediatrics 1998; 101(5):E13.

66. Premachandra DJ, Milton CM. Cat scratch disease in the parotid gland presenting with facial paralysis. Br J Oral Maxillofac Surg 1990; 28(6):413-415.

67. Yose M, Nishihira O, Inoue S, et al. Facial nerve palsy due to cat scratch disease. Facial Nerve Res 1985; 5:167-169.

68. Jagoda A, Riggio S, Burguieres T. Cephalic tetanus: a case report and review of the literature. Am J Emerg Med 1988; 6(2):128-130.

69. Vakil B.J, Singhal BS, Pandya SS, et al. Cephalic tetanus. Neurology 1973; 23(10):1091-1096.

70. Rose E. Der starrkrampf beim menschen. Deutsche Chirurgie 1897; 3:358-374.

71. Russel BW. Diseases of the Nervous System. 3rd ed. London: Oxford University Press, 1948:783.

72. Binet T. Sur le tetanus cephalique. Rev Chir (Paris) 1909; 50:427-439.

73. Brunner C. Experimentelle und klinische studien uber den kopftetanus. Zuricher Chirurgishchen Klinik 1894; 11:307-348.

74. Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med 1988; 85(3):391-398.

75. al Dousary S, Attallh M, al Rabah A, et al. Otitis externa malignant. A case report and review of literature. Otolaryngol Pol 1998; 52(1):19-22.

76. Hybels RL, Rice DH. Neuro-otologic manifestations of sarcoidosis. Laryngoscope 1976; 86(12):1873-1878.

77. James DG. Differential diagnosis of facial nerve palsy. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14 (2):115-120.

78. Lower EE, Broderick JP, Brott TG, et al. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157(16):1864-1868.

79. Glocker FX, Seifert C, Lucking CH. Facial palsy in Heerfordt's syndrome: electrophysiological localization of the lesion. Muscle Nerve 1999; 22(9):1279-1282.

80. Bopp FP, Cheney ML, Donzis PB, et al. Heerfordt syndrome: a cause of facial paralysis. J La State Med Soc 1990; 142(2):13-15.

81. Dutt SN, Mirza S, Irving RM, et al. Total decompression of facial nerve for Melkersson-Rosenthal syndrome. J Laryngol Otol 2000; 114(11):870-873.

82. Tamaki H, Ogino S, Miyaguchi M. Recurrent facial palsy. In: Graham M, House W, eds. Disorders of the Facial Nerve. New York, New York: Raven Press, 1982:243-248.

83. Graham MD, Kemink JL. Total facial nerve decompression in recurrent facial paralysis and the Melkersson-Rosenthal syndrome: a preliminary report. Am J Otol 1986; 7(1):34-37.

84. http://www.guillain-barre.com/overview.html (accessed October 2005).

85. Keane JR. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology 1994; 44(7):1198-1202.

86. Guillain G. Les Polyradiculonevrites avec dissociation albumino cytologique et a evolution favorable (syndrome de Guillain et Barre). J Belge Neurol Psychiatr 1938; 38:323-329.

87. Shuaib A, Becker WJ. Variants of Guillain-Barre syndrome: Miller Fisher syndrome, facial diplegia and multiple cranial nerve palsies. Can J Neurol Sci 1987; 14(4):611-616.

88. Tos M. Facial palsy in Hand-Schuller-Christian's disease. Arch Otolaryngol 1969; 90(5):563-567.

89. Alexander EL. Central nervous system (CNS) manifestations of primary Sjogren's syndrome: an overview. Scand J Rheumatol Suppl 1986; 61:161-165.

90. Delalande S, de Seze J, Fauchais AL, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83(5):280-291.

91. Fukazawa T. Facial palsy in multiple sclerosis. J Neurol 1997; 244(10):631-633.

92. Adelman DC, Saltiel E, Klinenberg JR. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 1986; 15(3):185—199.

93. Feinglass EJ, Arnett FC, Dorsch CA, et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976; 55(4):323-339.

94. Blaustein DA, Blaustein SA. Antinuclear antibody negative systemic lupus erythematosus presenting as bilateral facial paralysis. J Rheumatol 1998; 25(4):798-800.

95. Carpenter RJ III, McDonald TJ, Howard FM Jr. The otolaryngologic presentation of amyotrophic lateral sclerosis. Otolaryngology 1978; 86(3 pt 1):479-484.

96. Sharp G. Mixed connective tissue disease. Bull Rheum Dis 1975; 25:828-831.

97. Nitsche A, Leiguarda RC, Maldonado Cocco JA, et al. Neurological features in overlap syndrome. Clin Rheumatol 1991; 10(1):5-9.

98. Alfaro-Giner A, Penarrocha-Diago M, Bagan-Sebastian JV. Orofacial manifestations of mixed connective tissue disease with an uncommon serologic evolution. Oral Surg Oral Med Oral Pathol 1992; 73(4):441-444.

99. Hamza M, Annabi A, Ayed K, et al. Mixed connective tissue disease (Sharp syndrome) with involvement of the trigeminal nerve and facial paralysis. Sem Hop 1983; 59(36):2555-2556.

100. Per-Lee JH, Parsons RC. Vasculitis presenting as otitis media. South Med J 1969; 62(2):161-165.

101. Rose GA, Spencer H. Polyarteritis nodosa. Q J Med 1957; 26(101):43-81.

102. Dudley JP, Goodman M. Periarteritis nodosa and bilateral facial paralysis. Arch Otolarygnol 1969; 90(2):139-146.

103. Drinias V, Florentzson R. Facial palsy and Wegener's granulomatosis. Am J Otolaryngol 2004; 25

104. de Groot K, Schmidt DK, Arlt AC, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001; 58(8):1215-1221.

105. Nishino H, Rubino FA, DeRemee RA, et al. Neurologic involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol 1993; 33(1):4-9.

106. McCaffrey TV, McDonald TJ, Facer GW, et al. Otologic manifestations of Wegener's granulomatosis. Otolaryngol Head Neck Surg 1980; 88(5):586-593.

107. Dagum P, Roberson JB Jr. Otologic Wegener's granulomatosis with facial nerve palsy. Ann Otol Rhinol Laryngol 1998; 10(7):555-559.

108. Kornblut AD, Wolff SM, Fauci AS. Ear disease in patients with Wegener's granulomatosis. Laryngoscope 1982; 92(7 pt 1):713-717.

109. Calonius IH, Christensen CK. Hearing impairment and facial palsy as initial signs of Wegener's granulomatosis. J Laryngol Otol 1980; 94(6):649-657.

110. Bibas A, Fahy C, Sneddon L, et al. Facial paralysis in Wegener's granulomatosis of the middle ear. J Laryngol Otol 2001; 115(4):304-306.

111. Bakshi SH, Oak JL, Chawla KP, et al. Facial nerve involvement in pseudotumor cerebri. J Postgrad Med 1992; 38(3):144-145.

112. Capobianco DJ, Brazis PW, Cheshire WP. Idiopathic intracranial hypertension and seventh nerve palsy. Headache 1997; 37(5):286-288.

113. Amano S, Hazama F. Neural involvement in Kawasaki disease. Acta Pathol Jpn 1980; 30(3):365-373.

114. Poon LK, Lun KS, Ng YM. Facial nerve palsy and Kawasaki disease. Hong Kong Med J 2000; 6 (2):224-226.

115. Park MS, Lee HY, Kim HM, et al. Facial nerve paralysis associated with Kawasaki disease. Yonsei Med J 1991; 32(3):279-282.

116. Little KH, Lee EL, Frenkel EP. Cranial nerve deficits due to amyloidosis associated with plasma cell dyscrasia. South Med J 1986; 79(6):677-681.

117. Traynor AE, Gertz MA, Kyle RA. Cranial neuropathy associated with primary amyloidosis. Ann Neurol 1991; 29(4):451-454.

118. Braganza RA, Tien R, Hoffman HT, et al. Amyloid of the facial nerve. Laryngoscope 1992; 102(12 pt 1):1372-1376.

119. Barker DJ, Clough PW, Guyer PB, et al. Paget's disease of bone in 14 British towns. Br Med J 1977; 1(6070):1181-1183.

120. Hullar TE, Lustig LR. Paget's disease and fibrous dysplasia. Otolaryngol Clin North Am 2003; 36

121. Megerian CA, Sofferman RA, McKenna MJ, et al. Fibrous dysplasia of the temporal bone: ten new cases demonstrating the spectrum of otologic sequelae. Am J Otol 1995; 16(4):408-419.

122. Johnston CC Jr, Lavy N, Lord T, et al. Osteopetrosis. A clinical, genetic, metabolic, and morphologic study of the dominantly inherited, benign form. Medicine (Baltimore) 1968; 47(2):149-167.

123. Dort JC, Pollak AC, Fisch U. The fallopian canal and facial nerve in sclerosteosis of the temporal bone: a histopathologic study. Am J Otol 1990; 11(5):320-325.

124. Hofmeyr LM, Hamersma H. Sclerosing bone dysplasias: neurologic assessment and management. Curr Opin Otolaryngol Head Neck Surg 2004; 12(5):393-397.

125. Miyamoto RT, House WF, Brackmann DE. Neurotologic manifestations of the osteopetroses. Arch Otolaryngol 1980; 106(4):210-214.

126. Albers JW, Fink JK. Porphyric neuropathy. Muscle Nerve 2004; 30(4):410-422.

127. Meyer UA, Schuurmans MM, Lindberg RL. Acute porphyrias: pathogenesis of neurological manifestations. Semin Liver Dis 1998; 18(1):43-52.

128. Cavanagh JB, Mellick RS. On the nature of peripheral nerve lesions associated with acute intermittent porphyria. J Neurol Neurosurg Psychiatry 1965; 28:320-327.

129. Weintraub MI. Facial diplegia. Arch Otolaryngol 1976; 102(5):311-312.

130. Spillane JA. The face in neurological diagnosis. Br J Hosp Med 1983; 30(5):321-322, 324-325.

131. Chia LG. Facial weakness without ocular weakness in myasthenia gravis. Muscle Nerve 1988; 11 (2):185-186.

132. Sanders V. Neurologic manifestations of myxoedema. N Engl J Med 1962; 266:599-603.

133. Cox NH, Chew D, Williams JG, et al. Bell's Palsy associated with hypothyroidism. Br J Clin Pract 1985; 39(4):158-159.

134. Earll JM, Kolb FO. Facial paralysis occurring with hypothyroidism. A report of two cases. Calif Med 1967; 106(1):56-58.

135. Watanabe K, Hagura R, Akanuma Y, et al. Characteristics of cranial nerve palsies in diabetic patients. Diabetes Res Clin Pract 1990; 10(1):19-27.

136. Takasu T. A study of the disorder of the nervous system in diabetes mellitus. Adv Neurol Sci 1964; 8:1.

137. Korczyn AD. Bell's palsy and diabetes mellitus. Lancet 1971; 1(7690):108-109.

138. Moxon M. Apoplexy into canal of Fallopius in a case of Bright's disease, causing facial paralysis. Trans Pathol Soc London 1869; 20:420-422.

139. Paine RS. Facial paralysis in children; review of the differential diagnosis and report of ten cases treated with cortisone. Pediatrics 1957; 19(2):303-316.

140. Clarke E, Murphy EA. Neurological manifestations of malignant hypertension. Br Med J 1956; 44 (5005):1319-1326.

141. Lloyd AV, Jewitt DE, Still JD. Facial paralysis in children with hypertension. Arch Dis Child 1966; 41(217):292-294.

142. Amberg S. Hypertension in the young. Am J Dis Child 1929; 37:335-350.

143. Rance CP, Arbus GS, Balfe JW, et al. Persistent systemic hypertension in infants and children. Pediatr Clin North Am 1974; 21(4):801-824.

144. Trompeter RS, Smith RL, Hoare RD, et al. Neurological complications of arterial hypertension. Arch Dis Child 1982; 57(12):913-917.

145. Tirodker UH, Dabbagh S. Facial paralysis in childhood hypertension. J Paediatr Child Health 2001; 37(2):193-194.

146. Voorhees RL, Zeitzer LD, Ross M. Hypertension and associated peripheral facial paralysis. Laryngoscope 1972; 82(5):899-902.

147. Siegler RL, Brewer ED, Corneli HM, et al. Hypertension first seen as facial paralysis: case reports and review of the literature. Pediatrics 1991; 87(3):387-389.

148. Harms MM, Rotteveel JJ, Kar NC, et al. Recurrent alternating facial paralysis and malignant hypertension. Neuropediatrics 2000; 31(6):318-320.

149. Hilsinger RL Jr, Adour KK, Doty HE. Idiopathic facial paralysis, pregnancy, and the menstrual cycle. Ann Otol Rhinol Laryngol 1975; 84(4 pt 1):433-442.

150. Gillman GS, Schaitkin BM, May M, et al. Bell's palsy in pregnancy: a study of recovery outcomes. Otolaryngol Head Neck Surg 2002; 126(1):26-30.

151. Falco NA, Eriksson E. Idiopathic facial palsy in pregnancy and the puerperium. Surg Gynecol Obstet 1989; 169(4):337-340.

152. Rosenbaum RB, Donaldson JO. Peripheral nerve and neuromuscular disorders. Neurol Clin 1994; 12(3):461-478.

153. Cohen Y, Lavie O, Granovsky-Grisaru S, et al. Bell palsy complicating pregnancy: a review. Obstet Gynecol Surv 2000; 55(3):184-188.

154. Pulec JL. Collected letter. Int Corresp Soc Opthalmol Otolaryngol 1974; 19:42-43.

155. Sendi P, Locher R, Bucheli B, et al. Intranasal influenza vaccine in a working population. Clin Infect Dis 2004; 38:974-980.

156. Zhou W, Pool V, DeStefano F, et al. A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004; 13(8):505-510.

157. Shaw FE Jr, Graham DJ, Guess HA, et al. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination. Am J Epidemiol 1988; 127(2):337-352.

158. Rice JP, Horowitz M, Chin D. Wernicke-Korsakoff syndrome with bilateral facial nerve palsies. J Neurol Neurosurg Psychiatry 1984; 47(12):1356-1357.

159. Zaloga GP, Deal J, Spurling T, et al. Unusual manifestations of arsenic intoxication. Am J Med Sci 1985; 289(5):210-214.

160. McCall WV, Coffey CE. Transient facial palsy during lithium toxicity. J Clin Psychopharmacol 1987; 7(4):280-281.

161. Lee RT, Oster MW, Balmaceda C, et al. Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel. Ann Oncol 1999; 10(10):1245-1247.

162. Sokoloff J, Wickbom I, McDonald D, et al. Therapeutic percutaneous embolization in intractable epistaxis. Radiology 1974; 111(2):285-287.

163. de Vries N, Versluis RJ, Valk J, et al. Facial nerve paralysis following embolization for severe epistaxis (case report and review of the literature). J Laryngol Otol 1986; 100(2):207-210.

164. Metson R, Hanson DG. Bilateral facial nerve paralysis following arterial embolization for epistaxis. Otolaryngol Head Neck Surg 1983; 91(3):299-303.

165. Rhee D, Myssiorek D, Zahtz G, et al. Recurrent attacks of facial nerve palsy as the presenting sign of leukemic relapse. Laryngoscope 2002; 112(2):235-237.

166. Sood BR, Sharma B, Kumar S, et al. Facial palsy as first presentation of acute myeloid leukemia. Am J Hematol 2003; 74(3):200-201.

167. Paparella MM, Berlinge NT, Oda M. Otological manifestations of leukemia. Laryngoscope 1973; 83(9):1510-1526.

168. Zappia JJ, Bunge FA, Koopmann CF Jr, et al. Facial nerve paralysis as the presenting symptom of leukemia. Int J Pediatr Otorhinolaryngol 1990; 19(3):259-264.

169. Gotay V. Unusual otologic manifestations of chronic lymphocytic leukemia. Laryngoscope 1976; 86(12):1856-1863.

170. Schattner A, Kozack N, Sandler A, et al. Facial diplegia as the presenting manifestation of acute lymphoblastic leukemia. Mt. Sinai J Med 2001; 68(6):406-409.

171. Chapman P, Johnson SA. Mastoid chloroma as relapse in acute myeloid leukemia. J Laryngol Otol 1980; 94(12):1423-1427.

172. Ho TP, Carrie S, Meikle D, et al. T-cell lymphoma presenting as acute mastoiditis with a facial palsy. Int J Pediatr Otorhinolaryngol 2004; 68(9):1199-1201.

173. Bockmuhl U, Bruchhage KL, Enzmann H. Primary non-Hodgkin's lymphoma of the temporal bone. Eur Arch Otorhinolaryngol 1995; 252(6):376-378.

174. Tucci DL, Lambert PR, Innes DJ Jr. Primary lymphoma of the temporal bone. Arch Otolaryngol Head Neck Surg 1992; 118(1):83-85.

175. Lang EE, Walsh RM, Leader M. Primary middle-ear lymphoma in a child. J Laryngol Otol 2003; 117(3):205-207.

176. Laubert A, Mausolf A, Bernhards J, et al. Non-Hodgkin's lymphoma: a differential diagnosis of otogenic facial paralysis. HNO 1991; 39(3):98-101.

177. Shone GR. Facial palsy due to myeloma of the temporal bone. J Laryngol Otol 1985; 99(9):907-908.

178. Marks PV, Brookes GB. Myelomatosis presenting as an isolated lesion in the mastoid. J Laryngol Otol 1985; 99(9):903-906.

179. Funakubo T, Kikuchi A. A case of myeloma with facial palsy. Acta Otolaryngol Suppl 1994; 511:200-203.

180. Quinodoz D, Dulguerov P, Kurt AM, et al. Multiple myeloma presenting with external ear canal mass. J Laryngol Otol 1998; 112(5):469-471.

181. Li W, Schachern PA, Morizono T, et al. The temporal bone in multiple myeloma. Laryngoscope 1994; 104(6 pt 1):675-680.

182. Schuuknecht HF. Neoplastic growth. In: Schuknecht HF, ed. Pathology of the Ear. 2nd ed. Philadelphia, Pennsylvania: Lea and Febiger, 1993:492-498.

Was this article helpful?

0 0
Delicious Diabetic Recipes

Delicious Diabetic Recipes

This brilliant guide will teach you how to cook all those delicious recipes for people who have diabetes.

Get My Free Ebook


Post a comment